Functional imaging of Rel expression in inflammatory processes using bioluminescence imaging system in transgenic mice

PLoS One. 2013;8(2):e57632. doi: 10.1371/journal.pone.0057632. Epub 2013 Feb 28.

Abstract

c-Rel plays important roles in many inflammatory diseases. Revealing the dynamic expression of c-Rel in disease processes in vivo is critical for understanding c-Rel functions and for developing anti-inflammatory drugs. In this paper, a transgenic mouse line, B6-Tg(c-Rel-luc)(Mlit), which incorporated the transgene firefly luciferase driven by a 14.5-kb fragment containing mouse c-Rel gene Rel promoter, was generated to monitor Rel expression in vivo. Luciferase expression could be tracked in living mice by the method of bioluminescence imaging in a variety of inflammatory processes, including LPS induced sepsis and EAE disease model. The luciferase expression in transgenic mice was comparable to the endogenous Rel expression and could be suppressed by administration of anti-inflammatory drug dexamethasone or aspirin. These results indicate that the B6-Tg(c-Rel-luc)(Mlit) mouse is a valuable animal model to study Rel expression in physiological and pathological processes, and the effects of various drug treatments in vivo.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology
  • Aspirin / pharmacology
  • Dexamethasone / pharmacology
  • Encephalomyelitis, Autoimmune, Experimental / chemically induced
  • Encephalomyelitis, Autoimmune, Experimental / genetics
  • Female
  • Gene Expression Regulation* / drug effects
  • Inflammation / genetics
  • Lipopolysaccharides / pharmacology
  • Luciferases, Firefly / genetics
  • Luminescent Measurements*
  • Male
  • Mice
  • Mice, Transgenic
  • Molecular Imaging*
  • Myelin-Oligodendrocyte Glycoprotein / adverse effects
  • Peptide Fragments / adverse effects
  • Proto-Oncogene Proteins c-rel / genetics*
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Transcription, Genetic / drug effects
  • Zymosan / pharmacology

Substances

  • Anti-Inflammatory Agents
  • Lipopolysaccharides
  • Myelin-Oligodendrocyte Glycoprotein
  • Peptide Fragments
  • Proto-Oncogene Proteins c-rel
  • RNA, Messenger
  • myelin oligodendrocyte glycoprotein (35-55)
  • Dexamethasone
  • Zymosan
  • Luciferases, Firefly
  • Aspirin

Grants and funding

This work was supported by the National Key Project [2010CB945501, 2010CB912604]; the National Natural Science Foundation of China (81171188); the Science and Technology Commission of Shanghai Municipality [08140900700, 08140901900, 10DZ2251500, 12140902100]; and the E-Institutes of Shanghai Municipal Education Commission [E03003]. (National Key Project:http://www.973.gov.cn/AreaAppl.aspx; The National Natural Science Foundation of China: http://www.nsfc.gov.cn/nsfc/cen/bzgh_125/index.html; The Science and Technology Commission of Shanghai Municipality: http://www.stcsm.gov.cn/structure/index.htm; The E-Institutes of Shanghai Municipal Education Commission: http://www.shmec.gov.cn/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.